Simon Pollett

SARS-CoV-2 BA.1 variant is neutralized by vaccine booster–elicited serum but evades most convalescent serum and therapeutic antibodies

Sabrina Lusvarghi, Simon Pollett, Sabari Nath Neerukonda et al. · Science Translational Medicine · 2022 · 94 citations · Full text

Immunology, Spike Gene, Sars-cov-2 Ba.1 Variant +16

Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection

Stephanie A Richard, Simon Pollett, Anthony C Fries et al. · JAMA Network Open · 2023 · 88 citations · Full text

Campylobacterantimicrobial resistance in Peru: a ten-year observational study

Simon Pollett, Claudio Rocha, Rito Zerpa et al. · BMC Infectious Diseases · 2012 · 73 citations · Full text

Comparison of the Vitek MS and Bruker Microflex LT MALDI-TOF MS platforms for routine identification of commonly isolated bacteria and yeast in the clinical microbiology laboratory

Eszter Deák, Carmen Charlton, April M. Bobenchik et al. · Diagnostic Microbiology and Infectious Disease · 2014 · 72 citations

Clinical Microbiology Laboratory, Medical Microbiology, Pathogen Detection +9

Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers

Si’Ana A. Coggins, Eric D. Laing, Cara Olsen et al. · Open Forum Infectious Diseases · 2021 · 69 citations · Full text